Microneedle technologies for (trans)dermal drug and vaccine delivery

被引:537
作者
van der Maaden, Koen [1 ]
Jiskoot, Wim [1 ]
Bouwstra, Joke [1 ]
机构
[1] Leiden Univ, LACDR, Div Drug Delivery Technol, Leiden, Netherlands
关键词
Microneedles; (Trans)dermal drug delivery; Vaccine delivery; Protein delivery; Protein degradation; Formulation; RANDOMIZED CONTROLLED SAFETY; IMMUNE TOLERANT MICE; VIRUS-LIKE PARTICLES; TRANSDERMAL DELIVERY; DISSOLVING MICRONEEDLES; POLYMER MICRONEEDLES; INSULIN DELIVERY; MICROFABRICATED MICRONEEDLES; METAL MICRONEEDLES; INSERTION FORCE;
D O I
10.1016/j.jconrel.2012.01.042
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Microneedles have been used for the dermal and transdermal delivery of a broad range of drugs, such as small molecular weight drugs, oligonucleotides, DNA, peptides, proteins and inactivated viruses. However, until now there are no microneedle-based (trans) dermal drug delivery systems on the market. In the past decade various types of microneedles have been developed by a number of production processes. Numerous geometries of microneedles have been designed from various materials. These microneedles have been used for different approaches of microneedle-based (trans) dermal drug delivery. Following a brief introduction about dermal and transdermal drug delivery, this review describes different production methods for solid and hollow microneedles as well as conditions that influence skin penetration. Besides, the four microneedle-based (trans) dermal drug delivery approaches are discussed: "poke and flow", "poke and patch", "poke and release", and "coat and poke". A separate section of this review is devoted to the use of microneedles for the delivery of therapeutic proteins and vaccines. Finally, we give our view on research and development that is needed to render microneedle-based (trans) dermal drug delivery technologies clinically useful in the near future. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:645 / 655
页数:11
相关论文
共 153 条
[1]  
Allen M.G., 2010, Microneedle Devices and Methods of Manufacture and Use Thereof, Patent No. [US 2010/0312191 A1, 20100312191]
[2]   Demonstrated Solid-State Stability of Parathyroid Hormone PTH(1-34) Coated on a Novel Transdermal Microprojection Delivery System [J].
Ameri, Mahmoud ;
Daddona, Peter E. ;
Maa, Yuh-Fun .
PHARMACEUTICAL RESEARCH, 2009, 26 (11) :2454-2463
[3]   Microneedles with Intrinsic Immunoadjuvant Properties: Microfabrication, Protein Stability, and Modulated Release [J].
Andrianov, Alexander K. ;
Marin, Alexander ;
DeCollibus, Daniel P. .
PHARMACEUTICAL RESEARCH, 2011, 28 (01) :58-65
[4]   Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization [J].
Andrianov, Alexander K. ;
DeCollibus, Daniel P. ;
Gillis, Helice A. ;
Kha, Henry H. ;
Marin, Alexander ;
Prausnitz, Mark R. ;
Babiuk, Lorne A. ;
Townsend, Hugh ;
Mutwiri, George .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (45) :18936-18941
[5]  
[Anonymous], MODIFIED RELEASE DRU
[6]  
Arakawa T., 2006, BIOPROCESS INT, V4, P42
[7]   Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[8]   Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats [J].
Badkar, Advait V. ;
Smith, Alan M. ;
Eppstein, Jonathan A. ;
Banga, Ajay K. .
PHARMACEUTICAL RESEARCH, 2007, 24 (07) :1389-1395
[9]   In vivo assessment of safety of microneedle arrays in human skin [J].
Bal, Suzanne M. ;
Caussin, Julia ;
Pavel, Stan ;
Bouwstra, Joke A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) :193-202
[10]   Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation [J].
Bal, Suzanne M. ;
Slutter, Bram ;
Jiskoot, Wim ;
Bouwstra, Joke A. .
VACCINE, 2011, 29 (23) :4025-4032